Clinical Trial Resource Center

Clinical Trial Resource Center

View By:Year | Company | Conditions | Therapeutic Areas | Drug Names

2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998 | 1997 | 1996 | 1995

FDA Approved Drugs

The following database contains a listing of drugs approved by the Food and Drug Administration (FDA) for sale in the United States. Drug information typically includes the drug name, approval status, indication of use, and clinical trial results. Review descriptions for our medical therapeutic area list to help assist in your search.

Join our Drug Research Updates group on LinkedIn! 

Find out more about the types of drugs included in this listing.

1999

Cardiology/Vascular Diseases

Lescol (fluvastatin sodium) capsules, Rx; Novartis; Treatment for the reduction of triglycerides, Approved June 1999

Mevacor (lovastatin) tablets; Merck; Treatment for primary prevention of coronary heart disease, Approved March 1999

Niaspan; Kos Pharmaceuticals; Niacin extended-release tablets, October 28, 1999

Dental and Oral Health

Atridox; Atrix Laboratories; Treatment of chronic adult periodontitis, Approved January 1999

Dermatology

Lamisil (terbinafine hydrochloride) Dermagel, 1%; Novartis; Treatment for tinea pedis (athlete's foot), Approved March 1999

Luxiq (betamethasone valerate) Foam; Connetics Corporation; Treatment for dermatoses of scalp, Approved June 1999

Endocrinology

ACTOS; Takeda; Treatment for type II diabetes, Approved July 1999

Aggrenox; Boehringer Ingelheim; Aggrenox (aspirin/extended-release dipyridamole) 25mg/200mg capules for the prevention of recurrence of stroke, Approved November 1999

Aromasin Tablets; Pharmacia & Upjohn; Exemestane Tablets, 25 mg, October 21, 1999

Avandia (rosiglitazone maleate); SmithKline Beecham; Treatment for type II diabetes mellitus, Approved June 1999

Cernevit; Baxter Healthcare; For the treatment of vitamin deficiency, Approved April 1999.

Climara; Berlex Laboratories; For the prevention of postmenopausal osteoporosis (loss of bone mass), Approved June 1999

Doxil (doxorubicin HCl liposome injection); Alza; Treatment for ovarian cancer that is refractory to other first-line therapies, Approved June 1999

Ellence; Pharmacia & Upjohn; epirubicin hydrochloride, Approved September 1999

Ethyol (amifostine); U.S. Bioscience, Alza; Treatment for xerostomia (dry mouth) due to radiation, Approved June 1999

Evista (raloxifene hydrochloride); Eli Lilly; Osteoporosis treatment, Approved September 1999

Femhrt Tablets; Parke-Davis; Norethindrone acetate (1mg) and ethinyl estradiol tablets (5mcg), October 15, 1999

Ortho-Prefest; Ortho-McNeil Pharmaceutical, R.W. Johnson; 17 beta estradiol/17 beta estradiol norgestimate tablets, October 22, 1999

Xenical/Orlistat Capsules; Roche; Treatment for obesity management, Approved April 1999

Family Medicine

Accolate; AstraZeneca; zafirlukast, 10 mg and 20 mg tablets., Approved September 1999

Aggrenox; Boehringer Ingelheim; Aggrenox (aspirin/extended-release dipyridamole) 25mg/200mg capules for the prevention of recurrence of stroke, Approved November 1999

Aromasin Tablets; Pharmacia & Upjohn; Exemestane Tablets, 25 mg, October 21, 1999

Comtan; Novartis; 200mg entacapone tablets, October 19, 1999

Ellence; Pharmacia & Upjohn; epirubicin hydrochloride, Approved September 1999

Evista (raloxifene hydrochloride); Eli Lilly; Osteoporosis treatment, Approved September 1999

Femhrt Tablets; Parke-Davis; Norethindrone acetate (1mg) and ethinyl estradiol tablets (5mcg), October 15, 1999

Keppra; UCB; Levetiracetam tablets for adjunctive treatment of partial onset seizures in adults with epilepsy, Approved November 1999

Ortho-Prefest; Ortho-McNeil Pharmaceutical, R.W. Johnson; 17 beta estradiol/17 beta estradiol norgestimate tablets, October 22, 1999

Synercid I.V.; Rhone Poulenc Rorer; quinupristin and dalfopristin for injection, Approved September 1999

Gastroenterology

Prevpac; TAP Pharmaceuticals; Treatment for eradication of H. pylori, Approved February 1999

Genetic Disease

Keppra; UCB; Levetiracetam tablets for adjunctive treatment of partial onset seizures in adults with epilepsy, Approved November 1999

Hematology

Aggrenox; Boehringer Ingelheim; Aggrenox (aspirin/extended-release dipyridamole) 25mg/200mg capules for the prevention of recurrence of stroke, Approved November 1999

Busulflex; Orphan Medical; For use in combination for the treatment of leukemia, Approved February 1999

Ferrlecit; R&D Laboratories; For the treatment of iron deficiency anemia., Approved February 1999

Fragmin; Pharmacia & Upjohn; Treatment of prophylaxis of deep vein thrombosis (DVT), Approved March 1999

Lovenox (enoxaparin sodium) Injection; Rhone Poulenc Rorer; Treatment for acute deep vein thrombosis, Approved January 1999

Immunology

Agenerase (amprenavir); GlaxoSmithKline; For the treatment of HIV-1 infection., Approved April 1999

Cleocin (clindamycin phosphate); Pharmacia & Upjohn; Treatment for bacterial vaginosis, Approved August 1999

Famvir (famciclovir); SmithKline Beecham; Treatment for Herpes Simplex Infections in HIV-infected patients, Approved January 1999

Norvir (ritonavir); Abbott Laboratories; Treatment for HIV infection, Approved June 1999

Panretin Gel; Ligand Pharmaceuticals; Treatment of cutaneous lesions in patients with AIDS-related Kaposi's sarcoma., Approved June 1999

Rapamune (sirolimus) oral solution; Wyeth; Oral solution of sirolimus, Approved September 1999

Relenza; GlaxoSmithKline; Treatment for uncomplicated acute illness due to influenza virus, Approved July 1999

Synercid I.V.; Rhone Poulenc Rorer; quinupristin and dalfopristin for injection, Approved September 1999

Tamiflu capsule; Roche; Oseltamivir phosphate capsule, October 27, 1999

Vistide (cidofovir); Gilead; For the treatment of cytomegalovirus (CMV) retinitis, Approved March 1999

Infections and Infectious Diseases

Nasonex Nasal Spray; Schering-Plough; Treatment of seasonal allergic rhinitis, Approved January 1999

Rhinocort Aqua Nasal Spray; AstraZeneca; A nasal spray containing budesonide, Approved October 1999

Synercid I.V.; Rhone Poulenc Rorer; quinupristin and dalfopristin for injection, Approved September 1999

Tamiflu capsule; Roche; Oseltamivir phosphate capsule, October 27, 1999

Musculoskeletal

Evista (raloxifene hydrochloride); Eli Lilly; Osteoporosis treatment, Approved September 1999

Femhrt Tablets; Parke-Davis; Norethindrone acetate (1mg) and ethinyl estradiol tablets (5mcg), October 15, 1999

Nephrology

Ditropan XL (oxybutynin chloride); Alza; Treatment for overactive bladder, Approved June 1999

Levaquin; R.W. Johnson; Treatment for urinary tract infection, Approved July 1999

Tequin; Bristol-Myers Squibb; Tequin (Injectable and Tablet), December, 1999

Neurology

Aggrenox; Boehringer Ingelheim; Aggrenox (aspirin/extended-release dipyridamole) 25mg/200mg capules for the prevention of recurrence of stroke, Approved November 1999

Cenestin; Duramed Pharmaceuticals; Treatment for symptoms associated with menopause, Approved July 1999

Comtan; Novartis; 200mg entacapone tablets, October 19, 1999

Keppra; UCB; Levetiracetam tablets for adjunctive treatment of partial onset seizures in adults with epilepsy, Approved November 1999

Lamictal (lamotrigine) Chewable Dispersible Tablets; GlaxoSmithKline; Treatment for epileptic seizures, Approved June 1999

Lidoderm Patch (lidocaine patch 5% ); Hind Health Care; Treatment of pain in post-herpetic neuralgia, Approved June 1999

Sonata; American Home Products; Treatment fo insomnia, Approved August 1999

Topamax (topiramate); Ortho-McNeil Pharmaceutical; Treatment for epilepsy in pediatric patients, Approved July 1999

Obstetrics/Gynecology (Women’s Health)

Aromasin Tablets; Pharmacia & Upjohn; Exemestane Tablets, 25 mg, October 21, 1999

Cenestin; Duramed Pharmaceuticals; Treatment for symptoms associated with menopause, Approved July 1999

Cenestin; Duramed Pharmaceuticals; Treatment for relief of vasomotor symptoms due to menopause, Approved March 1999

Cleocin (clindamycin phosphate); Pharmacia & Upjohn; Treatment for bacterial vaginosis, Approved August 1999

Climara; Berlex Laboratories; For the prevention of postmenopausal osteoporosis (loss of bone mass), Approved June 1999

Doxil (doxorubicin HCl liposome injection); Alza; Treatment for ovarian cancer that is refractory to other first-line therapies, Approved June 1999

Ellence; Pharmacia & Upjohn; epirubicin hydrochloride, Approved September 1999

Estradiol Transdermal System; Wyeth; Transdermal patch system for the treatement of vulvar vaginal atrophy and vasomotor symptoms., Approved September 1999

Evista (raloxifene hydrochloride); Eli Lilly; Osteoporosis treatment, Approved September 1999

Femhrt Tablets; Parke-Davis; Norethindrone acetate (1mg) and ethinyl estradiol tablets (5mcg), October 15, 1999

Lupron Depot (leuprolide acetate for depot suspension); TAP Pharmaceuticals; Treatment for endometriosis and uterine fibroids, Approved June 1999

Ortho-Prefest; Ortho-McNeil Pharmaceutical, R.W. Johnson; 17 beta estradiol/17 beta estradiol norgestimate tablets, October 22, 1999

Tequin; Bristol-Myers Squibb; Tequin (Injectable and Tablet), December, 1999

Oncology

Aromasin Tablets; Pharmacia & Upjohn; Exemestane Tablets, 25 mg, October 21, 1999

Busulflex; Orphan Medical; For use in combination for the treatment of leukemia, Approved February 1999

Doxil (doxorubicin HCl liposome injection); Alza; Treatment for ovarian cancer that is refractory to other first-line therapies, Approved June 1999

Ellence; Pharmacia & Upjohn; epirubicin hydrochloride, Approved September 1999

Ethyol (amifostine); U.S. Bioscience, Alza; Treatment for xerostomia (dry mouth) due to radiation, Approved June 1999

Temodar; Schering-Plough; Treatment for refractory anaplastic astrocytoma, Approved August 1999

UVADEX Sterile Solution; Therakos; Treatment of the skin manifestations of cutaneous T-cell lymphoma (CTCL), Approved February 1999

Zofran; GlaxoSmithKline; Treatment for the prevention of chemotherapy and radiation-induced nausea, Approved January 1999

Ophthalmology

Alamast; Santen; pemirolast potassium ophthalmic solution, Approved September 1999

ZADITOR; Ciba Vision; Treatment for the prevention of itching of the eye, Approved July 1999

Otolaryngology (Ear, Nose, Throat)

Ethyol (amifostine); U.S. Bioscience, Alza; Treatment for xerostomia (dry mouth) due to radiation, Approved June 1999

Pediatrics/Neonatology

Amoxil (amoxicillin); SmithKline Beecham; Treatment (antibiotic) for common bacteria, Approved July 1999

Topamax (topiramate); Ortho-McNeil Pharmaceutical; Treatment for epilepsy in pediatric patients, Approved July 1999

Pharmacology/Toxicology

Raplon; Organon; Adjunct to general anesthesia during surgical procedures, Approved August 1999

Psychiatry/Psychology

Effexor (venlafaxin HCL); Wyeth; Treatment for generalized anxiety disorder, Approved March 1999

Paxil CR (paroxetine hydrochloride); SmithKline Beecham; Treatment for depression, Approved March 1999

Sonata; American Home Products; Treatment fo insomnia, Approved August 1999

Pulmonary/Respiratory Diseases

Accolate; AstraZeneca; zafirlukast, 10 mg and 20 mg tablets., Approved September 1999

Cafcit Injection; Roxane Laboratories; For the short term treatment of apnea of prematurity in infants between 28 and <33 weeks gestational age., Approved September 1999

Proventil HFA Inhalation Aerosol; 3M Pharmaceuticals; Treatment or prevention of bronchospasm, Approved June 1999

Rhinocort Aqua Nasal Spray; AstraZeneca; A nasal spray containing budesonide, Approved October 1999

Tequin; Bristol-Myers Squibb; Tequin (Injectable and Tablet), December, 1999

Tikosyn Capsules; Pfizer; Capsules of dofetilide, Approved October 1999

Rheumatology

Lodine XL (etodolac); Wyeth; Treatment for the signs and symptoms of osteoarthritis and rheumatoid arthritis, Approved May 1999

Vaccines

Synercid I.V.; Rhone Poulenc Rorer; quinupristin and dalfopristin for injection, Approved September 1999

Tamiflu capsule; Roche; Oseltamivir phosphate capsule, October 27, 1999